Infection VIH: faisabilite d'une etude de seroprevalence avec consentement chez des patients hospitalises. [HIV infection: feasibility of a seroprevalence study with consent of hospitalized patients]
Details
Serval ID
serval:BIB_1202B5F5E720
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Infection VIH: faisabilite d'une etude de seroprevalence avec consentement chez des patients hospitalises. [HIV infection: feasibility of a seroprevalence study with consent of hospitalized patients]
Journal
Sozial- und Praventivmedizin
ISSN
0303-8408 (Print)
Publication state
Published
Issued date
1992
Volume
37
Number
5
Pages
207-12
Notes
English Abstract
Journal Article
Research Support, Non-U.S. Gov't
Journal Article
Research Support, Non-U.S. Gov't
Abstract
A pilot study was carried out in order to evaluate the feasibility of determining the seroprevalence rate of HIV infection and the prevalence of risk factors among selected hospital patients at the Centre Hospitalier Universitaire Vaudois (CHUV). Consent was obtained and only blood already obtained for other purposes was used for testing. Among 850 patients between 16 and 65 years of age and residing in Switzerland who were originally selected at random, only 200 patients were accessible for an interview and for whom blood was available in order to be included in the study. Of these, 165 (83%) accepted their blood to be tested. A seropositive result was identified in 2 patients already aware of their serostatus. The age distribution, diagnosis and behavioral risk factors (when available through the interview) were not different among those accepting the test and the ones refusing. However, foreigners were more likely to refuse the blood test than Swiss nationals, even though none of them came from a country with a high rate of endemicity for HIV infection. Reasons for refusal included the following: lack of risk factors 10 (29%), doubts about confidentiality 6 (17%), blood test already performed 5 (14%), language barrier 4 (11%) and others 10 (29%). We conclude that even though the data in our sample did not suggest that patients refusing the test were at an increased risk of being seropositive, it is unlikely that with such a refusal rate, a reliable measure of seroprevalence could be determined in the population of study with the methods used, especially when one is expecting a relatively low seroprevalence rate.
Keywords
AIDS Serodiagnosis
Adolescent
Adult
Aged
Blotting, Western
Cohort Studies
Confidentiality
Enzyme-Linked Immunosorbent Assay
Female
*HIV Seroprevalence
*Hospitalization
Humans
Informed Consent
Male
Middle Aged
Patient Compliance
Pilot Projects
Risk Factors
Pubmed
Web of science
Create date
25/01/2008 17:08
Last modification date
20/08/2019 12:39